TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate

- Hernández-Mitre, María Patricia, Morpeth, Susan C., Roberts, Jason A., Venkatesh, Balasubramanian, Hills, Thomas E., Davis, Joshua, Mahar, Robert K., McPhee, Grace, Jones, Mark, Totterdell, James, Tong, Steven Y. C.

A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus

- Henderson, Andrew, Cheng, Matthew P., Nguyen, Vi, Mora, Jocelyn M., Morpeth, Susan C., Robinson, James O., Tong, Stephen Y. C., Van Hal, Sebastiaan J., Microbiology Working Group of the Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group,, Chew, Ka Lip, Coombs, Geoffrey W., Davis, Joshua S., Grant, Jennifer M., Gregson, Dan, Giulieri, Stefano G., Howden, Benjamin P., Lee, Todd C.

A Randomized Trial of Nafamostat for Covid-19

- Morpeth, Susan C., Venkatesh, Balasubramanian, Burke, Andrew J., Cochrane, Belinda, Denholm, Justin T., Dhungana, Ashesh, Dore, Gregory J., Dotel, Ravindra, Duffy, Eamon, Dummer, Jack, Foo, Hong, Gilbey, Timothy L., Totterdell, James A., Hammond, NE, Hudson, BJ, Jha, V, Jevaji, PR, John, O, Joshi, R, Kang, G, Kaur, B, Kim, S, Das, SK, McPhee, Grace M., Lau, JSY, Littleford, R, Marsh, JA, Marschner, IC, Matthews, G, Maze, MJ, McArthur, CJ, McFadyen, JD, McMahon, JH, McQuilten, ZK, Mahar, Robert K., Molton, J, Mora, JM, Mudaliar, V, Nguyen, V, O'Sullivan, MVN, Pant, S, Park, JE, Paterson, DL, Price, DJ, Raymond, N, Jones, Mark, Rees, MA, Robinson, JO, Rogers, BA, Ryu, W-S, Sasadeusz, J, Shum, O, Snelling, TL, Sommerville, C, Trask, N, Lewin, SR, Bandara, Methma, Hills, TE, Davis, Joshua S., Roberts, JA, Tong, SYC, Barina, Lauren A., Basnet, Bhupendra K., Bowen, Asha C.